Gut microbiota and dysbiosis

There has been a growing interest within the medical and scientific community towards the microbial imbalance within the body – dysbiosis. The human gut microbiota provides essential roles in normal physiology for digestion and immunity. However, a microbial imbalance can result in a range of functional gastrointestinal disorders (FGID), cancer and diabetes. FGIDs inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn’s disease (CD), irritable bowel syndrome (IBS) and non-alcoholic steatohepatitis (NASH).

Analysing gut microbiota

In recent years, the diagnosis and treatment of dysbiosis has been of great interest to the medical and scientific community. Through microbiota research, there have been emerging strategies to treat FGID. The use of pre- and probiotics, antibiotics and faecal microbiota transplants (FMT) is providing new options for patients with chronic digestive disorders.